These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8730447)

  • 21. Salt and hypertension in end-stage renal disease.
    Shaldon S
    Blood Purif; 2000; 18(1):59. PubMed ID: 10686444
    [No Abstract]   [Full Text] [Related]  

  • 22. Carnitine metabolism in chronic renal failure. Acute effects of carnitine addition to the dialysate during acetate hemodialysis.
    Guarnieri G; Toigo G; Crapesi L; Situlin R; Del Bianco MA; Corsi M; Lo Greco P; Vasile A
    Contrib Nephrol; 1988; 65():1-23. PubMed ID: 3048873
    [No Abstract]   [Full Text] [Related]  

  • 23. Individualizing the dialysate in the hemodialysis patient.
    Palmer BF
    Semin Dial; 2001; 14(1):41-9. PubMed ID: 11208039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the length of each hemodialysis session by on-line dialysate urea monitoring.
    Hernandez-Herrera G; Martin-Malo A; Rodriguez M; Aljama P
    Nephron; 2001 Sep; 89(1):37-42. PubMed ID: 11528230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of recombinant human growth hormone in adults receiving maintenance hemodialysis.
    Ziegler TR; Lazarus JM; Young LS; Hakim R; Wilmore DW
    J Am Soc Nephrol; 1991 Dec; 2(6):1130-5. PubMed ID: 1777593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solute kinetics with short-daily home hemodialysis using slow dialysate flow rate.
    Kohn OF; Coe FL; Ing TS
    Hemodial Int; 2010 Jan; 14(1):39-46. PubMed ID: 19758296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does Hemodialysis Dialysate Potassium Composition Matter?
    Haras MS
    Nephrol Nurs J; 2015; 42(6):577-80; quiz 581. PubMed ID: 26875233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Removal of Phosphorus by Hemodialysis.
    Daugirdas JT
    Semin Dial; 2015; 28(6):620-3. PubMed ID: 26358370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of Dialysate Calcium Level Reduces Progression of Coronary Artery Calcification and Improves Low Bone Turnover in Patients on Hemodialysis.
    Ok E; Asci G; Bayraktaroglu S; Toz H; Ozkahya M; Yilmaz M; Kircelli F; Sevinc Ok E; Ceylan N; Duman S; Cirit M; Monier-Faugere MC; Malluche HH
    J Am Soc Nephrol; 2016 Aug; 27(8):2475-86. PubMed ID: 26701977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is 2.5 mEq/L the optimal calcium concentration of dialysate in the use of sevelamer hydrochloride? A study of the dialysate calcium concentration recommended by K/DOQI guidelines.
    Izumi M; Shirai K; Ito K; Miyamoto T; Matsumoto A; Takenaka Y; Nakagawa K; Yamanashi T; Takamitsu Y; Nakanish T
    Ther Apher Dial; 2005 Feb; 9(1):24-31. PubMed ID: 15828902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of hypophosphatemia induced by high-flux hemodiafiltration for the treatment of vancomycin toxicity: intravenous phosphorus therapy versus use of a phosphorus-enriched dialysate.
    Gatchalian RA; Popli A; Ejaz AA; Leehey DJ; Kjellstrand CM; Ing TS
    Am J Kidney Dis; 2000 Dec; 36(6):1262-6. PubMed ID: 11096051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies concerning the optimization of dialysate consumption.
    Sigdell JE; Tersteegen B
    Nephron; 1995; 71(4):401-6. PubMed ID: 8587619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug dosing considerations in alternative hemodialysis.
    Decker BS; Mueller BA; Sowinski KM
    Adv Chronic Kidney Dis; 2007 Jul; 14(3):e17-26. PubMed ID: 17603971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of reduced dialysate calcium on mineral metabolism in hemodialysis patients].
    Fujimori A; Yorifuji M; Sakai M; Fukagawa M
    Clin Calcium; 2005 Sep; 15 Suppl 1():121-4; discussion 124. PubMed ID: 16272643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [State of the art and outlook for promoting Russian-made hemodialysis equipment with regeneration of dialyzing solution].
    Viktorov VA; Varin AN; Grinval'd VM; Maksimov EP; Fomicheva NN; Zavalishin IuK; Leshchinskiĭ GM; Razhev II; Noskov SG; Shadiev BSh; Rodin VV; Strelkov SI; Shukov OV; Turiaev AD; Shishkin SV
    Med Tekh; 2003; (1):16-21. PubMed ID: 12608066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Continuous measurement of dialysate urea: using the advantages of the technique with expertise and empathy].
    Ehlert G
    Pflege Z; 2003 Jun; 56(6):403-6. PubMed ID: 12861937
    [No Abstract]   [Full Text] [Related]  

  • 38. Fluoridated water, hemodialysis, and renal disease.
    Med Lett Drugs Ther; 1969 Aug; 11(16):67-8. PubMed ID: 5820566
    [No Abstract]   [Full Text] [Related]  

  • 39. A fractional dialysate collection method to estimate solute removal in continuous venovenous hemodialysis.
    Kanagasundaram NS; Larive AB; Paganini EP
    Kidney Int; 2000 Dec; 58(6):2579-84. PubMed ID: 11115094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dialysate and Serum Potassium in Hemodialysis.
    Silva BC; Moyses RM; Elias RM
    Am J Kidney Dis; 2016 Jan; 67(1):165. PubMed ID: 26708195
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.